KDIGO 2012. Clinical practice guideline for the evaluation and management of chronic kidney disease. Dostępne na: http://kdigo.org/home/guidelines/ckd-evaluation-management data pobrania: 31.12.2013.
Iseki K, Ikemiya Y, Kinjo K, et al. Body Mass Index and the risk of development of end-stage renal disease in a sreened cohort.Kidney Int 2004; 65: 1870–1876.
Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity and the development of stege 3 CK D: the Framingham Heart Study. Am J Kid Dis 2008; 52: 39–48
Kawamoto R, Kohara K, Tabara Y, et al. An assotiation between Body Mass Index and Estimated Glomerular Filtration Rate.Hypertens Res 2008; 8: 31.
Kramer H, Luke A, Bidani A, et al. Obesity and prevalent and incident CK D: the Hypertension Detection and Follow-Up Program.Am J Kid Dis 2006; 46: 587–594.
Hill CJ, Cardwell CR , Maxwell AP, et al. Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit. QJM 2013; 106(10): 933–942
Mastalerz-Migas A, Zalasińska I, Muszyńska A, i wsp. Poziom glikemii a parametry funkcji nerek wśród pacjentów podstawowej opieki zdrowotnej – doniesienie wstępne. Fam Med Prim Care Rev 2008; 10(3): 515–518.
Singh NP . Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockroft--Gault and modification of diet in renal disease equation: an observational, cross-sectional study. BMC Nephrology 2009;10: 4.